12 Mar 2015 15:56
Bioquell: N+1 Singer upgrades from hold to buy with an unchanged target price of 112p. Investec cuts target price from 133p to 98p, while upgrading from hold to add. Circle Oil: Investec moves target price from 50p to 70p and maintains a buy recommendation. Clinigen Group: N+1 Singer ups target pr
Read moreThe healthcare sector was the only category in positive territory on Friday as investors sought defensive stocks in the face of a wider market sell-off. Meanwhile, results from medical devices maker Smith & Nephew were also encouraging investors in the healthcare space after modestly beating foreca
Read more